Europe Oligonucleotide Synthesis Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Europe Oligonucleotide Synthesis Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Europe Oligonucleotide Synthesis Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Europe Oligonucleotide Synthesis Market Regional Analysis

6.2 Europe Oligonucleotide Synthesis Market Revenue 2016-2027 (US$ Million)

6.3 Europe Oligonucleotide Synthesis Market Forecast Analysis

7. Europe Oligonucleotide Synthesis Market Analysis – by Product

7.1 Synthesized Oligonucleotides

7.1.1 Overview
7.1.2 Synthesized Oligonucleotides: Europe Oligonucleotide Synthesis Market – Revenue and Forecast, 2016-2027 (US$ Million)

7.2 Reagents

7.2.1 Overview
7.2.2 Reagents: Europe Oligonucleotide Synthesis Market – Revenue and Forecast, 2016-2027 (US$ Million)

7.3 Equipment

7.3.1 Overview
7.3.2 Equipment: Europe Oligonucleotide Synthesis Market – Revenue and Forecast, 2016-2027 (US$ Million)

8. Europe Oligonucleotide Synthesis Market Analysis – by Application

8.1 Research

8.1.1 Overview
8.1.2 Research: Europe Oligonucleotide Synthesis Market – Revenue and Forecast, 2016-2027 (US$ Million)

8.2 Diagnostics

8.2.1 Overview
8.2.2 Diagnostics: Europe Oligonucleotide Synthesis Market – Revenue and Forecast, 2016-2027 (US$ Million)

8.3 Therapeutics

8.3.1 Overview
8.3.2 Therapeutics: Europe Oligonucleotide Synthesis Market – Revenue and Forecast, 2016-2027 (US$ Million)

9. Europe Oligonucleotide Synthesis Market Analysis – by End User

9.1 Academic Research Institutes

9.1.1 Overview
9.1.2 Academic Research Institutes: Europe Oligonucleotide Synthesis Market – Revenue and Forecast, 2016-2027 (US$ Million)

9.2 Pharmaceutical & Biotechnology Companies

9.2.1 Overview
9.2.2 Pharmaceutical & Biotechnology Companies: Europe Oligonucleotide Synthesis Market – Revenue and Forecast, 2016-2027 (US$ Million)

9.3 Diagnostic Laboratories

9.3.1 Overview
9.3.2 Diagnostic Laboratories: Europe Oligonucleotide Synthesis Market – Revenue and Forecast, 2016-2027 (US$ Million)

9.4 Other End Users

9.4.1 Overview
9.4.2 Other End Users : Europe Oligonucleotide Synthesis Market – Revenue and Forecast, 2016-2027 (US$ Million)

10. Europe Oligonucleotide Synthesis Market – Europe Analysis

10.1 Overview

10.2 Europe

10.2.1 Europe Oligonucleotide Synthesis Market Breakdown, by Key Country, 2019 and 2027 (%)
10.2.1.1 Europe Oligonucleotide Synthesis Market – Revenue and Forecast Analysis – by Country
10.2.1.1 UK: Europe Oligonucleotide Synthesis Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.1.1 UK: Europe Oligonucleotide Synthesis Market Breakdown, by Product
10.2.1.1.2 UK: Europe Oligonucleotide Synthesis Market Breakdown, by Application
10.2.1.1.3 UK: Europe Oligonucleotide Synthesis Market Breakdown, by End User

10.2.1.2 Germany: Europe Oligonucleotide Synthesis Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.2.1 Germany: Europe Oligonucleotide Synthesis Market Breakdown, by Product
10.2.1.2.2 Germany: Europe Oligonucleotide Synthesis Market Breakdown, by Application
10.2.1.2.3 Germany: Europe Oligonucleotide Synthesis Market Breakdown, by End User

10.2.1.3 France: Europe Oligonucleotide Synthesis Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.3.1 France: Europe Oligonucleotide Synthesis Market Breakdown, by Product
10.2.1.3.2 France: Europe Oligonucleotide Synthesis Market Breakdown, by Application
10.2.1.3.3 France: Europe Oligonucleotide Synthesis Market Breakdown, by End User

10.2.1.4 Russia: Europe Oligonucleotide Synthesis Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.4.1 Russia: Europe Oligonucleotide Synthesis Market Breakdown, by Product
10.2.1.4.2 Russia: Europe Oligonucleotide Synthesis Market Breakdown, by Application
10.2.1.4.3 Russia: Europe Oligonucleotide Synthesis Market Breakdown, by End User

10.2.1.5 Italy: Europe Oligonucleotide Synthesis Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.5.1 Italy: Europe Oligonucleotide Synthesis Market Breakdown, by Product
10.2.1.5.2 Italy: Europe Oligonucleotide Synthesis Market Breakdown, by Application
10.2.1.5.3 Italy: Europe Oligonucleotide Synthesis Market Breakdown, by End User

10.2.1.6 Rest of Europe: Europe Oligonucleotide Synthesis Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.6.1 Rest of Europe: Europe Oligonucleotide Synthesis Market Breakdown, by Product
10.2.1.6.2 Rest of Europe: Europe Oligonucleotide Synthesis Market Breakdown, by Application
10.2.1.6.3 Rest of Europe: Europe Oligonucleotide Synthesis Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 Thermo Fisher Scientific Inc.

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 GenScript

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Molecular Assemblies

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Twist Biosciences

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Evonetix

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 DNA Script

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Nuclera Nucleics

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Camena Bioscience

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Synthomics

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Ansa Biotechnologies

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

Europe Oligonucleotide Synthesis Market

Analysis and Forecasts by Product (Synthesized Oligonucleotides, Reagents, and Equipment), Application (Research, Diagnostics, and Therapeutics), End User (Academic Research Institutes, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, and Other End Users)